Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Skeletal Radiology
Published in: Skeletal Radiology 11/2003

01-11-2003 | Article

Malignant fibrous histiocytoma: past, present, and future

Author: A. E. Rosenberg

Published in: Skeletal Radiology | Issue 11/2003

Login to get access

Excerpt

Few tumors have generated more controversy during the past several decades than malignant fibrous histiocytoma (MFH). To those at the periphery of the debate, MFH represents a common, aggressive, soft tissue sarcoma of adulthood. However, to those embroiled, MFH is either a wastebasket term for poorly differentiated sarcomas of a variety of different phenotypes, or a distinct clinicopathologic entity, albeit one having a misleading name. As a spark quickly becomes a flame, then grows into a roaring fire, only to diminish into a smoldering ember, so too has MFH run its nosological course. The widespread recognition and popularity that soon followed its initial description has dwindled over the past decade as the entity MFH has fallen into disrepute. …
Literature
1.
Garrett CA. Tumors of xanthoma type. Arch Surg 1924; 8:890–907.
2.
Senear FE, Caro MR. Histiocytoma cutis. Arch Dermat Syph 1936; 33:209–226.
3.
Gross RE, Wolbach SB. Sclerosing hemangiomas; their relationship to dermatofibroma, histiocytoma, xanthoma and to certain pigmented lesions of the skin. Am J Pathol 1943; 19:553–561.
4.
Murray MR, Stout AP. Tissue culture in tumor classification and diagnosis. In: Pack GT, Ariel IM, eds. Treatment of cancer and allied disease. New York: Paul B. Hoeber, 1958: 124–139.
5.
Ozzello L, Stout AP, Murray MR. Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 1963; 16:331–344.
6.
O'Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer 1964; 17:1445–1451.
7.
Weiss SW. 44th Maude Abbott Lecture. Soft tissue sarcomas: lessons from the past, challenges for the future. Mod Pathol 2002; 15(1):77–86.
8.
Enzinger FM, Lattes R, Torloni H. Histologic typing of soft tissue tumors. Geneva: World Health Organization, 1969.
9.
Kempson RL, Kyriakos M. Fibroxanthosarcoma of the soft tissues. A type of malignant fibrous histiocytoma. Cancer 1972; 29(4):961–976.
10.
Soule EH, Enriquez P. Atypical fibrous histiocytoma, malignant fibrous histiocytoma, malignant histiocytoma, and epithelioid sarcoma. A comparative study of 65 tumors. Cancer 1972; 30(1):128–143.
11.
Kahn LB. Retroperitoneal xanthogranuloma and xanthosarcoma (malignant fibrous xanthoma). Cancer 1973; 31(2):411–422.
12.
Fu YS, et al. Malignant soft tissue tumors of probable histiocytic origin (malignant fibrous histiocytomas): general considerations and electron microscopic and tissue culture studies. Cancer 1975; 35(1):176–198.
13.
Merkow LP, et al. Ultrastructure of a fibroxanthosarcoma (malignant fibroxanthoma). Cancer 1971; 28(2):372–383.
14.
Taxy JB, Battifora H. Malignant fibrous histiocytoma. An electron microscopic study. Cancer 1977; 40(1):254–267.
15.
Limacher J, Delage C, Lagace R. Malignant fibrous histiocytoma. Clinicopathologic and ultrastructural study of 12 cases. Am J Surg Pathol 1978; 2(3):265–274.
16.
Guccion JG, Enzinger FM. Malignant giant cell tumor of soft parts. An analysis of 32 cases. Cancer 1972; 29(6):1518–1529.
17.
Weiss SW, Enzinger FM. Myxoid variant of malignant fibrous histiocytoma. Cancer 1977; 39(4):1672–1685.
18.
Enzinger FM. Angiomatoid malignant fibrous histiocytoma: a distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm. Cancer 1979; 44(6):2147–2157.
19.
Kyriakos M, Kempson RL. Inflammatory fibrous histiocytoma. An aggressive and lethal lesion. Cancer 1976; 37(3):1584–1606.
20.
Lattes R. Malignant fibrous histiocytoma. A review article. Am J Surg Pathol 1982; 6(8):761–771.
21.
Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 1978; 41(6):2250–2266.
22.
Enjoji M, et al. Malignant fibrous histiocytoma. A clinicopathologic study of 130 cases. Acta Pathol Jpn 1980; 30(5):727–741.
23.
Kearney MM, Soule EH, Ivins JC. Malignant fibrous histiocytoma: a retrospective study of 167 cases. Cancer 1980; 45(1):167–178.
24.
Patel SR. Radiation-induced sarcoma. Curr Treat Options Oncol 2000; 1(3):258–261.
25.
Rooser B, et al. Malignant fibrous histiocytoma of soft tissue. A population-based epidemiologic and prognostic study of 137 patients. Cancer 1991; 67(2):499–505.
26.
Pezzi CM, et al. Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer 1992; 69(8):2098–2103.
27.
Le Doussal V, et al. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis. Cancer 1996; 77(9):1823–1830.
28.
Salo JC, et al. Malignant fibrous histiocytoma of the extremity. Cancer 1999; 85(8):1765–1772.
29.
Gibbs JF, et al. Malignant fibrous histiocytoma: an institutional review. Cancer Invest 2001; 19(1):23–27.
30.
Oda Y, et al. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts. Pathol Int 2002; 52(9):595–606.
31.
Lawson CW, Fisher C, Gatter KC. An immunohistochemical study of differentiation in malignant fibrous histiocytoma. Histopathology 1987; 11(4):375–383.
32.
Fisher C. The value of electron microscopy and immunohistochemistry in the diagnosis of soft tissue sarcomas: a study of 200 cases. Histopathology 1990; 16(5):441–454.
33.
Rosenberg AE, et al. Expression of epithelial markers in malignant fibrous histiocytoma of the musculoskeletal system: an immunohistochemical and electron microscopic study. Hum Pathol 1993; 24(3):284–293.
34.
Montgomery E, Fisher C. Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study. Histopathology 2001; 38(6):499–509.
35.
Wood GS, et al. Malignant fibrous histiocytoma tumor cells resemble fibroblasts. Am J Surg Pathol 1986; 10(5):323–335.
36.
Iwasaki H, et al. Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin immunocytochemical studies with monoclonal anti-MFH antibodies. Am J Pathol 1987; 128(3):528–537.
37.
Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992; 16(3):213–228.
38.
Fletcher CD, et al. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 2001; 19(12):3045–3050.
39.
Fletcher CD, Unni KK, Mertens F. World Health Organization classification of tumors. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002.
40.
Mentzel T, et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 1996; 20(4):391–405.
41.
Fanburg-Smith JC, Miettinen M. Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype. Hum Pathol 1999; 30(11):1336–1343.
42.
Antonescu CR, Erlandson RA, Huvos AG. Primary fibrosarcoma and malignant fibrous histiocytoma of bone--a comparative ultrastructural study: evidence of a spectrum of fibroblastic differentiation. Ultrastruct Pathol 2000; 24(2):83–91.
43.
Kesavan S, et al. The reclassification of MFH as fibrosarcoma: a proposal based on the analysis of the the ultrastructural features of 100 cases. Mod Pathol 2001; 14: p. 14a (abstract 59).
44.
Suh CH, Ordonez NG, Mackay B. Malignant fibrous histiocytoma: an ultrastructural perspective. Ultrastruct Pathol 2000; 24(4):243–250.
45.
Kindblom LG, Widehn S, Meis-Kindblom JM. The role of electron microscopy in the diagnosis of pleomorphic sarcomas of soft tissue. Semin Diagn Pathol 2003; 20(1):72–81.
46.
Nielsen TO, et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 2002; 359(9314):1301–1307.
47.
Lee YF, et al. Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling. Br J Cancer 2003; 88(4):510–515.
48.
Ren B, et al. Gene expression analysis of human soft tissue leiomyosarcomas. Hum Pathol 2003; 34(6):549–558.
Metadata
Title
Malignant fibrous histiocytoma: past, present, and future
Author
A. E. Rosenberg
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
Skeletal Radiology / Issue 11/2003
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-003-0686-1

Other articles of this Issue 11/2003

Skeletal Radiology 11/2003 Go to the issue

Article

MR imaging for preoperative diagnosis and assessment of local tumor extent on localized giant cell tumor of tendon sheath

Article

Arcuate sign of posterolateral knee injuries: anatomic, radiographic, and MR imaging data related to patterns of injury

Case Report

Mycotic osteomyelitis due to Scedosporium Apiospermum: MR imaging-pathologic correlation

Editorial

Skeletal Radiology—manuscript processing goes online

Case Report

Isolated intraosseous gout in hallux sesamoid mimicking a bone tumor in a teenaged patient

Article

Unilateral hypertrophy of tensor fascia lata: a soft tissue tumor simulator